TY - CHAP
T1 - Measuring the Efficacy of Cross-Linking Clinical Metrics
AU - Bradley Randleman, J.
AU - Thulasi, Praneetha
N1 - Publisher Copyright:
© 2017 by Taylor & Francis Group.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - It is now widely accepted that corneal cross-linking (CXL) improves both patient visual outcomes and corneal parameters in patients with keratoconus and ectasia. In the laboratory, it is relatively straightforward to evaluate CXL efficacy using a variety of stress-strain measurement strategies (see Chapter 24). However, quantifying cross-linking efficacy clinically has proven difficult. Various parameters have been used to measure change in corneal structure, each with its own benefits and pitfalls. This chapter examines a few of these challenges.
AB - It is now widely accepted that corneal cross-linking (CXL) improves both patient visual outcomes and corneal parameters in patients with keratoconus and ectasia. In the laboratory, it is relatively straightforward to evaluate CXL efficacy using a variety of stress-strain measurement strategies (see Chapter 24). However, quantifying cross-linking efficacy clinically has proven difficult. Various parameters have been used to measure change in corneal structure, each with its own benefits and pitfalls. This chapter examines a few of these challenges.
UR - http://www.scopus.com/inward/record.url?scp=85200284654&partnerID=8YFLogxK
U2 - 10.1201/9781003523314-26
DO - 10.1201/9781003523314-26
M3 - Chapter
AN - SCOPUS:85200284654
SN - 9781630912109
SP - 151
EP - 156
BT - Corneal Cross-Linking
PB - CRC Press
ER -